Radboud University Medical Center
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
PSMA-PET Imaging Before and After ADT in Advanced SDC Patients
Not Applicable
- Conditions
- Salivary Duct CarcinomaSalivary Gland Cancer
- Interventions
- Diagnostic Test: 68Ga-PSMA-PET/CTDiagnostic Test: 18FDG-PET/CT
- First Posted Date
- 2020-01-02
- Last Posted Date
- 2022-08-16
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 14
- Registration Number
- NCT04214353
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients
Phase 2
Completed
- Conditions
- Endometrial Cancer
- Interventions
- Biological: Dendritic Cells for endometrial cancer
- First Posted Date
- 2019-12-27
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 8
- Registration Number
- NCT04212377
- Locations
- 🇳🇱
Radboud University Medical Center, Nijmegen, Netherlands
The Benefit of UHR-CT: Precision of Repeated Volume Measurements of Pulmonary Nodules
Not Applicable
Completed
- Conditions
- Pulmonary Nodule, Solitary
- Interventions
- Device: Genesis high-end CT scannerDevice: Precision Ultra-High-Resolution CT scanner
- First Posted Date
- 2019-12-24
- Last Posted Date
- 2019-12-24
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 92
- Registration Number
- NCT04209972
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
Hepatitis C Elimination in the Netherlands
- Conditions
- Chronic Hepatitis c
- First Posted Date
- 2019-12-23
- Last Posted Date
- 2019-12-23
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 250
- Registration Number
- NCT04208035
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery
- Conditions
- Colonic NeoplasmsEsophageal CancerRectum NeoplasmPancreatic Ductal AdenocarcinomaGastrointestinal CancerEsophageal NeoplasmsGastrointestinal MicrobiomePancreatic CancerMicrobiotaColorectal Cancer
- First Posted Date
- 2019-12-06
- Last Posted Date
- 2019-12-06
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT04189393
Clinical Outcomes After Implementation of COntinuous Vital Sign Monitoring On the General Ward.
Completed
- Conditions
- Clinical Deterioration
- Interventions
- Other: Continuous Monitoring
- First Posted Date
- 2019-12-06
- Last Posted Date
- 2022-09-07
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 3896
- Registration Number
- NCT04189653
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
Turner Syndrome Minipuberty Study
Recruiting
- Conditions
- Turner SyndromeInfertility, FemalePremature Ovarian FailureOvarian DiseasesPremature MenopauseSex Chromosome DisordersGonadal Dysgenesis
- Interventions
- Other: Venapunction
- First Posted Date
- 2019-12-06
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT04189406
- Locations
- 🇩🇪
Justus-Liebig Universität Giessen, Gießen, Germany
🇳🇱University medical center Groningen, Groningen, Netherlands
🇳🇱Leiden University medical center, Leiden, Netherlands
Improving Gait Adaptability in Hereditary Spastic Paraplegia
Not Applicable
Completed
- Conditions
- Hereditary Spastic ParaplegiaStrumpell Disease
- Interventions
- Behavioral: C-mill interventionOther: No intervention
- First Posted Date
- 2019-11-27
- Last Posted Date
- 2022-04-29
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 36
- Registration Number
- NCT04180098
- Locations
- 🇳🇱
Radboud universitair medisch centrum, Nijmegen, Netherlands
Functional Improvement of Coronary Artery Narrowing by Cholesterol Reduction With a PCSK9 Antibody
Not Applicable
Completed
- Conditions
- Coronary Artery DiseaseAtherosclerosis of Coronary Artery
- Interventions
- Drug: PlaceboDrug: Evolocumab 140 MG/ML [Repatha]
- First Posted Date
- 2019-10-28
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 150
- Registration Number
- NCT04141579
- Locations
- 🇳🇱
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands
Treatment of Anastomotic Leakage After Rectal Cancer Resection
- Conditions
- Anastomotic Leak RectumRectal Cancer
- First Posted Date
- 2019-10-16
- Last Posted Date
- 2019-10-21
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 1246
- Registration Number
- NCT04127734
© Copyright 2025. All Rights Reserved by MedPath